Polar Capital’s Loxo Oncology, Inc LOXO Stock Holding History

Polar Capital’s Portfolio LOXO Stock Details LOXO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-356,621	Closed	-$50M	–	300
2018 Q4	$50M	Sell	356,621 -154,529	-30%	-$23.5M	0.53%	60
2018 Q3	$87.3M	Sell	511,150 -6,221	-1%	-$1.05M	0.74%	35
2018 Q2	$89.8K	Buy	517,371 +32,678	+7%	+$4.91M	0.54%	28
2018 Q1	$55.9M	Buy	484,693 +2,893	+0.6%	+$308K	0.56%	55
2017 Q4	$40.6M	Buy	481,800 +21,800	+5%	+$1.82M	0.42%	77
2017 Q3	$42.4M	Buy	460,000 +90,000	+24%	+$6.99M	0.48%	63
2017 Q2	$29.7M	Buy	370,000 +69,785	+23%	+$3.87M	0.4%	92
2017 Q1	$12.6M	Buy	300,215 +230,033	+328%	+$9.47M	0.19%	134
2016 Q4	$2.25M	Buy	+70,182	New	+$1.8M	0.04%	225

Other funds holding LOXO

IUHSA

Itau Unibanco Holding S.A. Sao Paulo, Brazil $4.31B AUM 46.57% 1-Year Est. Return

Polar Capital's LOXO Position: Q1 2019 in Review

Polar Capital sold out of Loxo Oncology, Inc (LOXO) in Q1 2019, closing a stake of 356,621 shares — an estimated $50M sold.

Polar Capital first reported a position in LOXO in Q4 2016 and held it in 9 quarters. The position peaked at $87.3M in Q3 2018. 1 fund tracked by Wall St. Rank holds LOXO as of Q1 2019.

Polar Capital reported no remaining Loxo Oncology, Inc position as of Q1 2019 after selling out during the quarter.
Polar Capital sold 356,621 Loxo Oncology, Inc shares in Q1 2019, an estimated $50M.
Polar Capital first reported a position in Loxo Oncology, Inc in Q4 2016 and held it in 9 quarters.
Polar Capital's Loxo Oncology, Inc position peaked at $87.3M in Q3 2018.
1 fund tracked by Wall St. Rank held Loxo Oncology, Inc as of Q1 2019.

Based on Polar Capital's 13F filing for Q1 2019, filed 15 May 2019.